142 related articles for article (PubMed ID: 2480210)
21. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
Zhao XY; Li N; Ding HG; Jiang FF
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
[TBL] [Abstract][Full Text] [Related]
22. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
24. Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
Yasmin Anum MY; Looi ML; Nor Aini AH; Merican I; Wahidah A; Mohd Radzi AH; Nor Azizah A; Othman NH
Med J Malaysia; 2009 Sep; 64(3):223-7. PubMed ID: 20527273
[TBL] [Abstract][Full Text] [Related]
25. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
[TBL] [Abstract][Full Text] [Related]
26. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
El-Shayeb AF; El-Habachi NM; Mansour AR; Zaghloul MS
Medicine (Baltimore); 2021 Apr; 100(17):e25112. PubMed ID: 33907088
[TBL] [Abstract][Full Text] [Related]
27. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
[TBL] [Abstract][Full Text] [Related]
28. [Value of serum glycosidase spectrum in the diagnosis of hepatocellular carcinoma].
Zhang SM
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):143-6. PubMed ID: 1319891
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP).
Baig JA; Alam JM; Mahmood SR; Baig M; Shaheen R; Sultana I; Waheed A
J Ayub Med Coll Abbottabad; 2009; 21(1):72-5. PubMed ID: 20364746
[TBL] [Abstract][Full Text] [Related]
30. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
[TBL] [Abstract][Full Text] [Related]
31. [Combined five tumor markers in detecting primary hepatic carcinoma].
Ma J; Gong Q; Lin M; Xi Y; Wang M; Chen Z; Pei Z; Ma W
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):14-6. PubMed ID: 11831976
[TBL] [Abstract][Full Text] [Related]
32. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
33. Markers for hepatocellular carcinoma.
Wu AH; Sell S
Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
[TBL] [Abstract][Full Text] [Related]
34. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of alpha-fetoprotein concentration in patients with chronic liver diseases].
Wójtowicz-Chomicz K; Cichoz-Lach H; Lis E; Kowalik A; Słomka M
Pol Merkur Lekarski; 2012 Jun; 32(192):374-7. PubMed ID: 22891562
[TBL] [Abstract][Full Text] [Related]
36. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellualar carcinoma serum markers.
Bertino G; Ardiri A; Malaguarnera M; Malaguarnera G; Bertino N; Calvagno GS
Semin Oncol; 2012 Aug; 39(4):410-33. PubMed ID: 22846859
[TBL] [Abstract][Full Text] [Related]
38. Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?
Deugnier Y; David V; Brissot P; Mabo P; Delamaire D; Messner M; Bourel M; Legall JY
Hepatology; 1984; 4(5):889-92. PubMed ID: 6207091
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
[TBL] [Abstract][Full Text] [Related]
40. Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.
Chen K; Zhang H; Zhang LN; Ju SQ; Qi J; Huang DF; Li F; Wei Q; Zhang J
World J Gastroenterol; 2013 May; 19(20):3143-9. PubMed ID: 23716996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
